1. Home
  2. News
  3. Immutep Ltd
  4. Immutep Receives A$3.4 million R&D French Tax Incentive
More Immutep Ltd news
Immutep LtdASX: IMM

Immutep Receives A$3.4 million R&D French Tax Incentive

Sep 28, 2021 at 11:08 PM EDT · Issued by Immutep Ltd

Filed with ASX · Sep 28, 2021 at 11:08 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/immutep-receives-adollar3.4-million-randd-french-tax-incentive

Immutep Ltd on 6ix

Story so far

  • Immutep receives $3.6M R&D French tax incentiveMay 29, 2020
  • Immutep receives A$2.5M R&D French Tax IncentiveOct 10, 2019

Earlier from Immutep

  • Recruitment of patients completed for Part B of TACTI-002Sep 1, 2021
  • Immuteps partner, EOC Pharma, expands efti trial pipelineAug 30, 2021
  • Chinese patent granted for anti-LAG-3 antibody LAG525Aug 26, 2021
  • INSIGHT-003 investigator-initiated trial - 1st patient dosedAug 4, 2021
  • Completion of Placement - Tranche 2Jul 29, 2021

Later from Immutep

  • Immutep Quarterly Activities Report & Appendix 4COct 27, 2021
  • Immutep receives EMA scientific advice for Phase 3 in MBCOct 28, 2021
  • Immutep granted Chinese Patent for eftilagimod alphaNov 2, 2021
  • Immutep announces publication of SITC 2021 abstractsNov 9, 2021
  • Immutep announces publication of SITC 2021 postersNov 14, 2021
All Immutep news releases↗

Follow Immutep into a list and get an email when it puts out news.

Follow Immutep
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer